It is clear that the pharmaceutical industry needs to evolve, but in which direction and how quickly? One thing is certain: Rewards will be great for companies that tap into new opportunities and align their business models and strategies for the future. In this complimentary webinar (Thursday, June 24), pharmaceutical industry strategist Robin Arnold, vice president of IMS Health’s Product and Portfolio Strategy practice, will reveal insights from the company’s recent global study of pharmaceutical market growth opportunities over the next decade.
For more information, or to register for this complimetary webinar, click here!
The study uncovers new insights about the most promising areas for long-term investment and de-prioritization, the potential of R&D pipelines, emerging therapy approaches and the impact of early patient intervention on growth, along with raising important questions about how pharmaceutical companies can better prepare for a more promising, but uncertain future.
After this program, you’ll better understand:
- The forecasted value of the pharmaceutical market through the year 2020
- Key trends and growth opportunities by disease area
- Commonalities and differences among drug market segments and disease areas
- Potential strategic management challenges and opportunities
For more information, or to register for this complimetary webinar, click here!
